Psoriasis Management During Pregnancy and In Pediatric Patients

Speciality: Dermatology


Speaker:

Prof. Dr. Ricardo Romiti | International Speaker, Responsible for the Psoriasis Unit at the Department of Dermatology

Dr Murlidhar Rajagopalan | Chairperson, M.B.B.S., MD(DERM), (PGIMER) FRCP Edinburgh, Head – Dermatology

Dr Sachin Varma | Speaker, MD, FAAD, Medical Director & Head

Description:

A warm welcome to all the medical professionals in this interesting session of management of psoriasis. In this webinar, the speakers, Prof. Dr. Ricardo Romiti, Dr Murlidhar Rajagopalan, and Dr Sachin Varma have shared the important facts associated with incidence and management of psoriasis.

Psoriasis is a skin condition, where itchy, scaly patches kind of rashes develop mostly on the knees, elbows, trunk and scalp. It is a common, long-term (chronic) disease with no potential cure. The condition can be painful and can interfere with activities like sleeping and concentrating.

Basically steroid creams or ointments (topical corticosteroids) are used to treat the disease condition. However, in special cases like pregnancy, care needs to be taken in prescribing the medicines.

Moreover, psoriasis is common dermatosis in children also, the majority of the psoriatic population develop the disease condition during their early phase of life. Hence, ensuring prevention and control during pediatric onset of psoriasis is considerably important. 

Therefore,  get an overall knowledge regarding psoriasis management in different patients like pediatrics, pregnant women etc. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
 


See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Why preventive mastectomy isn't offered to everyone at risk

2.

Financial hardship common in patients with cancer

3.

Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests.

4.

Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL

5.

Severe obesity associated with reduced prevalence of recommended cancer screenings


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot